CompoAtlas

A'ra Gout Relief

Natural health product licensed in Canada

Other names
A'ra Celeryseed' Cherry Complex
Licence holder
Aurora Biotechnology Canada Inc
NPN or DIN-HM
80086305
Status
Active licence
Licence date
18 June 2018
Revision date
Not provided
Form
Capsule, dur
Route of administration
Orale
Application type
Non traditionnelle

If this product were sold in France

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Malpighia emarginata

Source : Fruit

100 mgNot calculated
Mentha x piperita

Source : Feuille

Extract : Matériel brut sec

Extraction ratio : 15:1

Dry plant equivalent : 900 mg

60 mgNot calculated
Apium graveolens

Source : Graine(s)

100 mgNot calculated
Thymus vulgaris

Source : Feuille

100 mgNot calculated
Vitamine C

Source : Ascorbate de calcium

30 mg270,000 µg

Non-medicinal ingredients

Maltodextrine, Cellulose microcristalline, Stéarate de magnésium, Hypromellose, Pullulane

PopulationAgeQuantity per servingFrequency
Adultesminimum: 19 years3 Capsule3 days

Uses authorised in Canada

Text supplied in English because no French text is available.

(1) Celery see is traditionally used in herbal medicine to relieve the pain associated with gout and arthritis. (2) Source of antioxidants for the maintenance of good health.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80086305

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line